Skip to main content
main-content

Obstetrics and gynaecology

Obstetrics and gynaecology

25-02-2020 | Rheumatology | News | Article

ACR issues guidelines on reproductive health in people with rheumatic diseases

The ACR has released guidelines for reproductive healthcare among people with rheumatic and musculoskeletal diseases.

10-10-2019 | Rheumatology | News | Article

Dose of corticosteroid key to preterm birth risk in RA

Women with rheumatoid arthritis should avoid medium to high levels of oral corticosteroids during early or late pregnancy, say researchers who found an association with increased risk for preterm birth.

02-08-2019 | Diabetes | News | Article

Maternal blood glucose levels, BMI linked to stillbirth risk

A Scottish study has identified glycated hemoglobin levels and BMI as modifiable risk factors for stillbirth among pregnant women with diabetes.

30-05-2019 | Rheumatology | News | Article

EULAR publishes recommendations for managing antiphospholipid syndrome

Evidence-based recommendations for the management of antiphospholipid syndrome in adult patients have been issued by EULAR.

18-03-2019 | Oncology | News | Article

Infertility linked to increased risk for multiple cancer types

Women with infertility have a significantly higher risk than those without for both hormonal and nonhormonal cancers, but the absolute risk in both groups is low, shows an analysis of US insurance claims data.

08-03-2019 | Diabetes | News | Article

CONCEPTT data show substantial cost savings with CGM in pregnancy

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

11-02-2019 | Oncology | News | Article

ART-conceived children not at increased risk for cancer

Children conceived using assisted reproductive technology do not have an increased cancer risk relative to either the general population or naturally conceived children of women with impaired fertility, shows a Dutch study with a long follow-up.

28-01-2019 | Rheumatology | News | Article

Women with RA should expect a reduced success rate after assisted reproduction

Women with rheumatoid arthritis have a significantly lower chance of having a live birth following assisted reproductive technology treatment than women without RA, researchers report in the Annals of the Rheumatic Diseases.

07-12-2018 | Oncology | News | Article

Polycystic ovary syndrome associated with increased cancer risk

Women with polycystic ovary syndrome may have an increased likelihood for developing cancer, although the excess risk appears to be primarily restricted to those who are premenopausal, indicates a population-based study.

22-10-2018 | Oncology | News | Article

Maintenance olaparib ‘big step forward’ for BRCA-mutated advanced ovarian cancer

Progression-free survival is significantly improved with the use of maintenance olaparib in women with newly diagnosed FIGO stage III or IV ovarian cancer and a BRCA1/2 mutation, shows the placebo-controlled SOLO1 trial.

11-09-2018 | Leukaemia | News | Article

Maternal hormonal contraceptive use linked to childhood non-lymphoid leukemia risk

The use of hormonal contraceptives just before and during pregnancy may significantly increase the risk for childhood non-lymphoid leukemia, Danish researchers report.

06-09-2018 | Rheumatology | News | Article

Increased risk for preterm delivery in women with RA and JIA

Women with rheumatoid arthritis and those with juvenile idiopathic arthritis have a significantly elevated risk for preterm delivery, according to a prospective cohort study published in Arthritis Care & Research.

17-08-2018 | Oncology | News | Article

Catch-up HPV vaccination supported in older adolescence

US researchers have found evidence to support catch-up vaccination against the human papillomavirus in women given their first dose in older adolescence.

15-08-2018 | Oncology | News | Article

Apatinib–etoposide shows promise in platinum-resistant ovarian cancer

Oral etoposide plus apatinib is associated with a good objective response rate and manageable toxicity in heavily pretreated Chinese women with platinum-resistant or refractory ovarian cancer, according to results of the phase II AEROC study.

03-08-2018 | Oncology | News | Article

‘Reassuring’ childbirth rate reported for Hodgkin lymphoma survivors

The birth rate for women who are relapse-free after treatment for Hodgkin lymphoma has risen in recent years, becoming comparable with that of the general population regardless of disease stage or treatment.

25-07-2018 | Oncology | News | Article

Assisted reproduction linked to increased breast and ovarian cancer risk

Women who undergo assisted reproduction may be at increased risk for in situ breast cancer, and invasive and borderline ovarian tumors, show results of a large, population-based study.

16-07-2018 | Rheumatology | News | Article

TNF inhibitor discontinuation during pregnancy associated with increased flare risk

Women with inflammatory arthritis who discontinue tumor necrosis factor inhibitor therapy during pregnancy may be at increased risk for flare, researchers report.

19-02-2018 | Gynaecological cancer | News | Article

Chemoradiotherapy benefits demonstrated in locally advanced cervical cancer

Cisplatin chemoradiotherapy significantly delays disease recurrence and improves survival compared with radiotherapy alone in women with stage IIIB squamous cell carcinoma of the cervix, phase III study data show.

14-12-2017 | Breast cancer | News | Article

Short-term GnRHa therapy may prevent breast cancer chemotherapy-related ovarian dysfunction

Temporary ovarian suppression with a gonadotropin-releasing hormone analog alongside neoadjuvant or adjuvant chemotherapy could help preserve ovarian function and fertility in premenopausal women with early-stage breast cancer, shows a pooled analysis.

11-08-2017 | Gynaecological cancer | News | Article

Olaparib tablets improve PFS in BRCA1/2 mutated relapsed ovarian cancer

Maintenance therapy with olaparib, given in the newer tablet formulation, significantly improves progression-free survival compared with placebo in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation, phase III trial data show.

Image Credits